
Targeted breast cancer treatment approved for routine NHS use
Women with advanced breast cancer could soon have access to a new targeted treatment on the NHS, following a decision by the National Institute for Health and Care Excellence (NICE). The tablet capivasertib, used alongside fulvestrant, has been approved …